|
Sep 8, 2010
|
U.S. Patent and Trademark Office Approves Patent that extends ADXS Technology HER2/neu for use in Listeria and Protein Vaccines
|
|
Aug 24, 2010
|
European Patent Office Allows Advaxis/U. Penn Modified LLO Patent
|
|
Aug 20, 2010
|
US Patent & Trademark Office to Allow for New Advaxis Patent
|
|
Aug 3, 2010
|
ADXS Gets Formal Go-Ahead from India's DCGI to Conduct Phase II Cervical Cancer Trial
|
|
Jun 23, 2010
|
Advaxis Completes Dosing of Vanguard Patient Group in Phase II Cervical Dysplasia Clinical Trial
|
|
Jun 3, 2010
|
Advaxis Annual Meeting Recap
|
|
Jun 2, 2010
|
Advaxis and Department of Homeland Security Agree to Cooperative Research and Development Agreement
|
|
May 28, 2010
|
Advaxis Doses First Cervical Dysplasia Clinical Trial Patient
|
|
May 26, 2010
|
**** IMPORTANT WEBCAST LINK FOR NOBLE CONFERENCE ***
|
|
May 25, 2010
|
ADVAXIS INVITES SHAREHOLDERS TO THE 2010 ADVAXIS ANNUAL GENERAL MEETING
|
|
May 25, 2010
|
ADVAXIS TO PRESENT AT THE NOBLE FINANCIAL SIXTH ANNUAL EQUITY GROWTH CONFERENCE - ONTRACT 2010
|
|
May 18, 2010
|
ADVAXIS AND THE UNIVERSITY OF PENNSYLVANIA REACH AGREEMENT
|
|
Apr 15, 2010
|
ADVAXIS INITIATES PHASE II CERVICAL DYSPLASIA (CIN) TRIAL
|
|
Mar 25, 2010
|
ADVAXIS TO PRESENT AT THE 6TH ANNUAL SPRING GROWTH STOCK CONFERENCE
|
|
Mar 22, 2010
|
ADVAXIS IMMUNOTHERPEUTIC ADXS11-001 PHASE 1 SURVIVAL DATA EXTENDED
|
|
Mar 18, 2010
|
ADVAXIS RESEARCH IN ACTA SHOWS THERAPEUTIC ANTI-CANCER RESPONSE
|
|
Mar 17, 2010
|
ADVAXIS SCHEDULES ANNUAL GENERAL MEETING
|
|
Mar 11, 2010
|
ADVAXIS DEVELOPS ROOM TEMPERATURE FORMULATION OF ADXS11-001
|
|
Mar 10, 2010
|
EQUITY RESEARCH REPORT ON ADVAXIS UPDATED
|
|
Mar 8, 2010
|
ADVAXIS CONFIRMS LONG-TERM STABILITY OF LISTERIA-BASED IMMUNOTHERAPEUTICS' FORMULATIONS
|
|
Mar 4, 2010
|
ADVAXIS TO PRESENT AT THE FRENCH BIOTECH TOUR
|
|
Feb 19, 2010
|
ADVAXIS ANNOUNCES YEAR END 2009 RESULTS
|
|
Feb 19, 2010
|
ADVAXIS SUBMITS 10-K FOR FISCAL YEAR 2009
|
|
Feb 19, 2010
|
ADVAXIS CHAIRMAN/CEO THOMAS A. MOORE ISSUES STATEMENT
|
|
Feb 1, 2010
|
ADVAXIS CHAIRMAN/CEO THOMAS A. MOORE INTERVIEWED
|
|
Jan 27, 2010
|
ADVAXIS RECEIVES $278,978 IN NON-DILUTIVE TAX CREDIT SALE
|
|
Jan 22, 2010
|
ADVAXIS ISSUED NEW INTELLECTUAL PROPERTY PATENT
|
|
Jan 8, 2010
|
ADVAXIS TO PRESENT AT THE SIDOTI MICROCAP 2010 INVESTOR CONFERENCE
|
